IOM Urges Centralizing CTSA Leadership, Expanding Collaborations in Program's Next Phase | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institutes of Health's Clinical and Translational Science Awards program is "contributing significantly" to the development of advancement of new clinical and translational research in the US, but some organizational changes, refocusing, and accountability could improve the program, according to the Institute of Medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.